In vitro lymphocyte blastogenesis: a prognostic test in patients with neoplastic disease.
D000230:Adenocarcinoma / Q000276:immunology; D000293:Adolescent; D000328:Adult; D000368:Aged; D002283:Carcinoma, Bronchogenic / Q000276:immunology; D018288:Carcinoma, Small Cell / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002648:Child; D004247:DNA / Q000096:biosynthesis; D005260:Female; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D037102:Lectins / Q000494:pharmacology; D007945:Leukemia, Lymphoid / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009108:Mumps Vaccine / Q000008:administration & dosage; D009369:Neoplasms / Q000175:diagnosis*; D011379:Prognosis; D012075:Remission, Spontaneous; D012882:Skin Tests; D014316:Tritium; D014374:Tuberculin Test; D005719:gamma-Globulins / Q000032:analysis
D037102:Lectins; D009108:Mumps Vaccine; D005719:gamma-Globulins; D014316:Tritium; D004247:DNA